{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:02:50Z","timestamp":1777870970197,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014803","name":"European Food Safety Authority","doi-asserted-by":"publisher","award":["OC\/EFSA\/SCER\/2021\/13"],"award-info":[{"award-number":["OC\/EFSA\/SCER\/2021\/13"]}],"id":[{"id":"10.13039\/100014803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014803","name":"European Food Safety Authority","doi-asserted-by":"publisher","award":["2022KS9FZX"],"award-info":[{"award-number":["2022KS9FZX"]}],"id":[{"id":"10.13039\/100014803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.toxlet.2025.111817","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T15:49:34Z","timestamp":1767455374000},"page":"111817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An integrated in vitro and in silico testing strategy applied to PFAS inhibition of antibody production to define a tolerable daily intake"],"prefix":"10.1016","volume":"416","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-6704","authenticated-orcid":false,"given":"Martina","family":"Iulini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aafke W.F.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Beekmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Styliani","family":"Fragki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Paini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2025.111817_bib1","unstructured":"Allen J.G. Opinion: These toxic chemicals are everywhere \u2014 even in your body. And they won't ever go away. The Washington Post. 2 January 2018. ISSN 0190-8286. \u3008https:\/\/www.washingtonpost.com\/opinions\/these-toxic-chemicals-are-everywhere-and-they-wont-ever-go-away\/2018\/01\/02\/82e7e48a-e4ee-11e7-a65d-1ac0fd7f097e_story.html\u3009."},{"issue":"1-2","key":"10.1016\/j.toxlet.2025.111817_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-4274(02)00375-2","article-title":"Toxicokinetic modeling and its applications in chemical risk assessment","volume":"138","author":"Andersen","year":"2003","journal-title":"Toxicol. Lett."},{"issue":"16","key":"10.1016\/j.toxlet.2025.111817_bib3","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1021\/es501955g","article-title":"Application of mass balance models and the chemical activity concept to facilitate the use of in vitro toxicity data for risk assessment","volume":"48","author":"Armitage","year":"2014","journal-title":"Environ. Sci. Technol."},{"issue":"11","key":"10.1016\/j.toxlet.2025.111817_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/toxics9110315","article-title":"Update and evaluation of a high-throughput in vitro mass balance distribution model: IV-MBM EQP v2.0","volume":"9","author":"Armitage","year":"2021","journal-title":"Toxics"},{"key":"10.1016\/j.toxlet.2025.111817_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.comtox.2017.10.001","article-title":"Ab initio chemical safety assessment: A workflow based on exposure considerations and non-animal methods","volume":"4","author":"Berggren","year":"2017","journal-title":"Comput. Toxicol."},{"issue":"1","key":"10.1016\/j.toxlet.2025.111817_bib6","first-page":"55","article-title":"Serum concentrations of legacy, alternative, and precursor per- and polyfluoroalkyl substances: a descriptive analysis of adult female participants in the MIREC-ENDO study","volume":"23","author":"Borghese","year":"2024","journal-title":"Environmental health a global access science source"},{"issue":"7","key":"10.1016\/j.toxlet.2025.111817_bib7","first-page":"1057","article-title":"Exposure to per- and polyfluoroalkyl substances (PFASs) in healthcare: environmental and clinical insights","volume":"15","author":"Briassoulis","year":"2025","journal-title":"Life (Basel Switz. )"},{"issue":"5","key":"10.1016\/j.toxlet.2025.111817_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/20024091064264","article-title":"Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry","volume":"32","author":"Clewell","year":"2002","journal-title":"Crit. Rev. Toxicol."},{"issue":"8","key":"10.1016\/j.toxlet.2025.111817_bib9","article-title":"EFSA Project on the use of NAMs to explore the immunotoxicity of PFAS","volume":"21","author":"Corsini","year":"2024","journal-title":"EFSA Support. Publ. 2024"},{"issue":"9","key":"10.1016\/j.toxlet.2025.111817_bib10","article-title":"Risk to human health related to the presence of perfluoroalkyl substances in food","volume":"18","author":"EFSA CONTAM PANEL","year":"2020","journal-title":"EFSA J."},{"issue":"1","key":"10.1016\/j.toxlet.2025.111817_bib11","first-page":"19","article-title":"Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)","volume":"22","author":"Ehrlich","year":"2023","journal-title":"Environmental health a global access science source"},{"issue":"3","key":"10.1016\/j.toxlet.2025.111817_bib12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/etc.4890","article-title":"Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research","volume":"40","author":"Fenton","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"issue":"1","key":"10.1016\/j.toxlet.2025.111817_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/10408444.2023.2194913","article-title":"Weight of evidence evaluation for chemical-induced immunotoxicity for PFOA and PFOS: findings from an independent panel of experts","volume":"53","author":"Garvey","year":"2023","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.toxlet.2025.111817_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105583","article-title":"Environmental contamination and human exposure to PFASs near a fluorochemical production plant: review of historic and current PFOA and GenX contamination in the Netherlands","volume":"137","author":"Gebbink","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.toxlet.2025.111817_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tox.2013.08.012","article-title":"Dose metric considerations in in vitro assays to improve quantitative in vitro\u2013in vivo dose extrapolations","volume":"332","author":"Groothuis","year":"2015","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.toxlet.2025.111817_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/pollutants4010009","article-title":"Overview of per- and polyfluoroalkyl substances (PFAS), their applications, sources, and potential impacts on human health","volume":"4","author":"Habib","year":"2024","journal-title":"Pollutants"},{"key":"10.1016\/j.toxlet.2025.111817_bib17","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1039\/D4SU00152D","article-title":"Addressing the persistence of per- and poly-fluoroalkyl substances (PFAS): current challenges and potential solutions","volume":"2","author":"Itumoh","year":"2024","journal-title":"RSC Sustain."},{"key":"10.1016\/j.toxlet.2025.111817_bib18","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1016\/j.csbj.2024.06.036","article-title":"Advancing PFAS risk assessment: integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety","volume":"23","author":"Iulini","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"5","key":"10.1016\/j.toxlet.2025.111817_bib19","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00204-025-03993-6","article-title":"In vitro approaches to investigate the effect of chemicals on antibody production: the case study of PFASs","volume":"99","author":"Iulini","year":"2025","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2025.111817_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2025.1665163","article-title":"Decoding PFAS immunotoxicity: a NAMs-based comparison of short vs. long chains","volume":"7","author":"Iulini","year":"2025","journal-title":"Front. Toxicol."},{"issue":"4","key":"10.1016\/j.toxlet.2025.111817_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/toxics12040271","article-title":"A comparison of in vitro points of departure with human blood levels for per- and polyfluoroalkyl substances (PFAS)","volume":"12","author":"Judson","year":"2024","journal-title":"Toxics"},{"issue":"4","key":"10.1016\/j.toxlet.2025.111817_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/tx100428e","article-title":"Estimating Toxicity-Related Biological Pathway Altering Doses for High-Throughput Chemical Risk Assessment","volume":"24","author":"Judson","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.111817_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.630457","article-title":"Derivation of a Human In Vivo Benchmark Dose for Perfluorooctanoic Acid From ToxCast In Vitro Concentration\u2013Response Data Using a Computational Workflow for Probabilistic Quantitative In Vitro to In Vivo Extrapolation","volume":"12","author":"Loizou","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.toxlet.2025.111817_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/toxsci\/kfq270","article-title":"The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man","volume":"118","author":"Louisse","year":"2010","journal-title":"Toxicological sciences official journal Society Toxicology"},{"issue":"2","key":"10.1016\/j.toxlet.2025.111817_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0272-0590(92)90047-L","article-title":"Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests","volume":"18","author":"Luster","year":"1992","journal-title":"Fundamental applied toxicology official journal Society Toxicology"},{"issue":"8","key":"10.1016\/j.toxlet.2025.111817_bib26","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/toxics13080658","article-title":"Visceral, neural, and immunotoxicity of per- and polyfluoroalkyl substances: a mini review","volume":"13","author":"Martano","year":"2025","journal-title":"Toxics"},{"key":"10.1016\/j.toxlet.2025.111817_bib27","series-title":"In Proceedings of the First ACM International Conference on Bioinformatics and Computational Biology (BCB '10)","first-page":"649","article-title":"Universal immune system simulator framework (UISS)","author":"Pappalardo","year":"2010"},{"key":"10.1016\/j.toxlet.2025.111817_bib28","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.csbj.2022.03.024","article-title":"Translatability and transferability of in silico models: context of use switching to predict the effects of environmental chemicals on the immune system","volume":"20","author":"Pappalardo","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"8","key":"10.1016\/j.toxlet.2025.111817_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/toxics12080605","article-title":"Understanding PFAS: occurrence, fate, removal, and effects","volume":"12","author":"Pan","year":"2024","journal-title":"Toxics"},{"issue":"1","key":"10.1016\/j.toxlet.2025.111817_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/toxsci\/kfz201","article-title":"Utility of in vitro bioactivity as a lower bound estimate of in vivo adverse effect levels and in risk-based prioritization","volume":"173","author":"Paul Friedman","year":"2020","journal-title":"Toxicological sciences official journal Society Toxicology"},{"key":"10.1016\/j.toxlet.2025.111817_bib31","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1016\/j.csbj.2022.10.032","article-title":"Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers","volume":"20","author":"Russo","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.toxlet.2025.111817_bib32","unstructured":"U.S. Environmental Protection Agency. (2012). Benchmark Dose Technical Guidance (EPA\/100\/R-12\/001). Washington, DC: Author. \u3008https:\/\/www.epa.gov\/sites\/default\/files\/2015-01\/documents\/benchmark_dose_guidance.pdf\u3009."},{"key":"10.1016\/j.toxlet.2025.111817_bib33","unstructured":"U.S. Environmental Protection Agency (EPA), Technical Fact Sheet: Drinking Water Health Advisories for Four PFAS (PFOA, PFOS, GenX Chemicals, and PFBS), EPA 822-F-22-002, Washington, DC, June 2022, available at \u3008https:\/\/www.epa.gov\/system\/files\/documents\/2022-06\/technical-factsheet-four-PFAS.pdf\u3009."},{"issue":"2","key":"10.1016\/j.toxlet.2025.111817_bib34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/toxsci\/kft204","article-title":"Dosimetric anchoring of in vivo and in vitro studies for perfluorooctanoate and perfluorooctanesulfonate","volume":"136","author":"Wambaugh","year":"2013","journal-title":"Toxicological sciences official journal Society Toxicology"},{"issue":"1","key":"10.1016\/j.toxlet.2025.111817_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/toxsci\/kfv171","article-title":"Incorporating high-throughput exposure predictions with dosimetry-adjusted in vitro bioactivity to inform chemical toxicity testing","volume":"148","author":"Wetmore","year":"2015","journal-title":"Toxicological sciences official journal Society Toxicology"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427425027638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427425027638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:54:02Z","timestamp":1777568042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427425027638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":35,"alternative-id":["S0378427425027638"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2025.111817","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrated in vitro and in silico testing strategy applied to PFAS inhibition of antibody production to define a tolerable daily intake","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2025.111817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111817"}}